Diabetes

News

Novo's diabetes pill beats injections in head-to-head trials

Novo Nordisk is making the case for its diabetes pill, which it hopes will allow it to fight off competition from rivals in a highly competitive market.

News

J&J seals $2.1bn deal on sale of major diabetes devices firm

As part of its ongoing divestment program, a deal worth $2.1 billion has been struck between Johnson & Johnson (J&J) and US private equity firm Platinum Equity over the sale of the

News

Novo expands type 1 diabetes R&D

Company will also focus on serious chronic diseases

News

Novo Nordisk ties discounts to adherence in SMS pilot

Novo Nordisk is working with a digital health start-up to link better medication adherence to lower medicine costs for diabetes patients in the US through a text messaging pilot.

News

Lilly researches cell therapies for type 1 diabetes with Sig...

Eli Lilly and Sigilon Therapeutics have announced a collaboration to develop therapies based around capsules of genetically-engineered stem cells to treat type 1 diabetes.

News

Novo cleared to add key data to Tresiba label

Novo Nordisk can add data showing Tresiba can reduce the risk of hypoglycaemia to its label, a development which should help its fight competition from cheaper alternati

Novo's diabetes pill beats injections in head-to-head trials

J&J seals $2.1bn deal on sale of major diabetes devices firm

Novo expands type 1 diabetes R&D

Novo Nordisk ties discounts to adherence in SMS pilot

Lilly researches cell therapies for type 1 diabetes with Sig...

Novo cleared to add key data to Tresiba label

Delivering the right behavioural ingredients for the moment,...

How to meet your physicians where they are online

Diabetes

Editor's Picks